Hyloris Pharmaceuticals: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
Hyloris Pharmaceuticals
NACE 82.990, Other business support services
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€1.2m
2024 · -€14.4m+€13.2m
Equity
€87.2m
2024 · €88.4m-€1.2m
Cash
€11.7m
2024 · €22.4m-€10.7m
Balance sheet total
€101.5m
2024 · €95.7m+€5.9m
Largest movements
Assets
- Financial fixed assets +€20.1m
up €20.1m (+32.0%), from €62.7m to €82.7m
of which Affiliated companies: +€20.1m
- Cash -€10.7m
down €10.7m (-47.9%), from €22.4m to €11.7m
mainly Investment in fixed assets (net) (-€20.2m) and Net result for the year (-€1.2m)
- Receivables within one year -€3.6m
down €3.6m (-37.2%), from €9.7m to €6.1m
of which Other amounts receivable: -€2.5m
Equity and liabilities
- Other debts +€6.9m
up €6.9m (+201%), from €3.4m to €10.3m
- Profit (loss) carried forward -€1.2m
down €1.2m (-3.6%), from -€33.3m to -€34.5m
Income statement
- Financial charges -€10.9m
down €10.9m (-93.4%), from €11.7m to €767,438
of which Non-recurring financial charges: -€11.5m
- Services and other goods -€3.2m
down €3.2m (-32.0%), from €10.1m to €6.9m
- Turnover -€2.1m
down €2.1m (-36.0%), from €6.0m to €3.8m
- Financial income -€854,772
down €854,772 (-46.7%), from €1.8m to €976,839
- Provisions -€770,046
down €770,046, from €385,023 to -€385,023
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
-€14.4m
Turnover
-€2.1m
Other operating income
+€326,658
Services and other goods
+€3.2m
Staff costs
-€290,591
Depreciation
+€74,499
Provisions
+€770,046
Other operating charges
-€1,764
Other operating items
+€844,529
Financial income
-€854,772
Financial charges
+€10.9m
Taxes
+€334,905
Result 2025
-€1.2m
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€9.8m
Investment
-€20.2m
Financing
-€300,000
Cash 2024
€22.4m
From operations (derived)
+€9.8m
Net result for the year
-€1.2m
Depreciation
+€40,144
Receivables after one year
+€58,164
Receivables within one year
+€3.6m
Deferred charges and accrued income
-€96,421
Provisions
-€385,023
Trade debts
+€788,089
Smaller working-capital items
+€83,497
Other debts
+€6.9m
Investment (derived)
-€20.2m
Investment in fixed assets (net)
-€20.2m
Financing
-€300,000
Debts after one year
-€300,000
Cash 2025
€11.7m
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €95,663,227 | €101,532,598 | +€5.9m | +6.1% |
| Fixed assets | 21/28 | €62,839,120 | €82,978,930 | +€20.1m | +32.0% |
| Intangible fixed assets | 21 | €178,117 | €256,427 | +€78,310 | +44.0% |
| Financial fixed assets | 28 | €62,661,003 | €82,722,503 | +€20.1m | +32.0% |
| Affiliated companies | 280/1 | €61,661,002 | €81,722,502 | +€20.1m | +32.5% |
| Participating interests | 280 | €61,661,002 | €81,722,502 | +€20.1m | +32.5% |
| Companies linked by participating interests | 282/3 | €1 | €1 | = | 0.0% |
| Participating interests | 282 | €1 | €1 | = | 0.0% |
| Other financial fixed assets | 284/8 | €1,000,000 | €1,000,000 | = | 0.0% |
| Shares | 284 | €1,000,000 | €1,000,000 | = | 0.0% |
| Current assets | 29/58 | €32,824,107 | €18,553,668 | -€14.3m | -43.5% |
| Amounts receivable after more than one year | 29 | €664,387 | €606,223 | -€58,164 | -8.8% |
| Other amounts receivable | 291 | €664,387 | €606,223 | -€58,164 | -8.8% |
| Amounts receivable within one year | 40/41 | €9,652,523 | €6,059,803 | -€3.6m | -37.2% |
| Trade receivables | 40 | €3,595,051 | €2,543,262 | -€1.1m | -29.3% |
| Other amounts receivable | 41 | €6,057,472 | €3,516,541 | -€2.5m | -41.9% |
| Cash at bank and in hand | 54/58 | €22,390,031 | €11,674,055 | -€10.7m | -47.9% |
| Deferred charges and accrued income | 490/1 | €117,166 | €213,587 | +€96,421 | +82.3% |
| Total equity and liabilities | 10/49 | €95,663,227 | €101,532,598 | +€5.9m | +6.1% |
| Equity | 10/15 | €88,360,668 | €87,154,867 | -€1.2m | -1.4% |
| Contributions | 10/11 | €121,653,449 | €121,653,449 | = | 0.0% |
| Capital | 10 | €140,002 | €140,002 | = | 0.0% |
| Issued capital | 100 | €140,002 | €140,002 | = | 0.0% |
| Contributions outside capital | 11 | €121,513,447 | €121,513,447 | = | 0.0% |
| Share premium | 1100/10 | €121,513,447 | €121,513,447 | = | 0.0% |
| Reserves | 13 | €5,000 | €5,000 | = | 0.0% |
| Non-distributable reserves | 130/1 | €5,000 | €5,000 | = | 0.0% |
| Legal reserve | 130 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€33,297,781 | -€34,503,582 | -€1.2m | -3.6% |
| Provisions and deferred taxes | 16 | €385,023 | - | -€385,023 | |
| Provisions for liabilities and charges | 160/5 | €385,023 | - | -€385,023 | |
| Other liabilities and charges | 164/5 | €385,023 | - | -€385,023 | |
| Amounts payable | 17/49 | €6,917,536 | €14,377,731 | +€7.5m | +108% |
| Amounts payable after more than one year | 17 | €300,000 | - | -€300,000 | |
| Other amounts payable | 178/9 | €300,000 | - | -€300,000 | |
| Amounts payable within one year | 42/48 | €6,585,530 | €14,299,269 | +€7.7m | +117% |
| Trade debts | 44 | €3,108,840 | €3,896,929 | +€788,089 | +25.3% |
| Suppliers | 440/4 | €3,108,840 | €3,896,929 | +€788,089 | +25.3% |
| Taxes, remuneration and social security | 45 | €44,917 | €81,958 | +€37,041 | +82.5% |
| Taxes | 450/3 | €7,167 | €11,031 | +€3,864 | +53.9% |
| Remuneration and social security | 454/9 | €37,750 | €70,927 | +€33,177 | +87.9% |
| Other amounts payable | 47/48 | €3,431,773 | €10,320,382 | +€6.9m | +201% |
| Accrued charges and deferred income | 492/3 | €32,006 | €78,462 | +€46,456 | +145% |
| Operating income | 70/76A | €6,219,903 | €5,242,127 | -€977,776 | -15.7% |
| Turnover | 70 | €5,966,698 | €3,817,735 | -€2.1m | -36.0% |
| Own construction capitalised | 72 | - | €25,990 | +€25,990 | |
| Other operating income | 74 | €253,205 | €579,863 | +€326,658 | +129% |
| Non-recurring operating income | 76A | - | €818,539 | +€818,539 | |
| Operating charges | 60/66A | €10,778,311 | €6,999,380 | -€3.8m | -35.1% |
| Services and other goods | 61 | €10,083,206 | €6,856,465 | -€3.2m | -32.0% |
| Remuneration, social security and pensions | 62 | €189,483 | €480,074 | +€290,591 | +153% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €114,643 | €40,144 | -€74,499 | -65.0% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €385,023 | -€385,023 | -€770,046 | |
| Other operating charges | 640/8 | €5,956 | €7,720 | +€1,764 | +29.6% |
| Operating profit (loss) | 9901 | -€4,558,408 | -€1,757,253 | +€2.8m | +61.5% |
| Financial income | 75/76B | €1,831,611 | €976,839 | -€854,772 | -46.7% |
| Recurring financial income | 75 | €1,831,611 | €976,839 | -€854,772 | -46.7% |
| Income from current assets | 751 | €1,521,112 | €777,217 | -€743,895 | -48.9% |
| Other financial income | 752/9 | €310,499 | €199,622 | -€110,877 | -35.7% |
| Financial charges | 65/66B | €11,671,555 | €767,438 | -€10.9m | -93.4% |
| Recurring financial charges | 65 | €171,555 | €767,438 | +€595,883 | +347% |
| Debt charges | 650 | €145,699 | €307,763 | +€162,064 | +111% |
| Other financial charges | 652/9 | €25,856 | €459,675 | +€433,819 | +1,678% |
| Non-recurring financial charges | 66B | €11,500,000 | - | -€11.5m | |
| Profit (loss) for the period before taxes | 9903 | -€14,398,352 | -€1,547,852 | +€12.9m | +89.2% |
| Income taxes | 67/77 | -€7,146 | -€342,051 | -€334,905 | -4,687% |
| Taxes | 670/3 | - | €1,616 | +€1,616 | |
| Tax adjustments and reversals of tax provisions | 77 | €7,146 | €343,667 | +€336,521 | +4,709% |
| Profit (loss) for the period | 9904 | -€14,391,206 | -€1,205,801 | +€13.2m | +91.6% |
| Profit (loss) for the period to be appropriated | 9905 | -€14,391,206 | -€1,205,801 | +€13.2m | +91.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.